Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes.
National Institute for Clinical Excellence (Great Britain)
London : National Institute for Clinical Excellence,
2002.
Cover title.
"This guidance replaces Technology appraisal guidance no. 12, issued in September 2000."
Includes bibliographical references.
Glycoproteins
Coronary heart disease